However, the finding that the accumulation of [111In]In-DOTA-Ahx-R954 is positively correlated with tumour B1R expression levels suggests potential clinical applications for radiolabelled derivatives of B1R antagonists, which have been actively studied as PET/SPECT probes. The gene discussed is BDKRB1; the disease is neoplasm.